Register
Think before you prescribe - Consider dual therapy in patients with atrial fibrillation undergoing PCI and stenting |
Editorial
eMediNexus Coverage from: 
Think before you prescribe - Consider dual therapy in patients with atrial fibrillation undergoing PCI and stenting
Dr KK Aggarwal,  14 September 2018
remove_red_eye 879 Views
#Multispeciality

2 Read Comments                

Dual antiplatelet therapy (DAPT), with aspirin and clopidogrel for 6-12 months, is usual after percutaneous coronary intervention (PCI) to prevent stent thrombosis and major adverse cardiac events (MACE) (J Thorac Cardiovasc Surg. 2016;152:1243-75). Because these patients are already on warfarin, an anti-Xa inhibitor (rivaroxaban or apixaban) or a direct thrombin inhibitor (dabigatran) as they have a separate indication for atrial fibrillation (AF), they are therefore subject to tri

To continue reading this article
Or

Continue reading your article with a Emedinexus account..
Free Membership!